Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer.
Guan J, Liu H, Chai Y, Yu J, Yao J, Wang J, Pan Z, Zhang J, Zhou Y, Liu H, Yao S, Qi J, Feng H, Gao GF, Wang Q, Shi Y, Tan S.
Guan J, et al. Among authors: zhou y.
MAbs. 2023 Jan-Dec;15(1):2153409. doi: 10.1080/19420862.2022.2153409.
MAbs. 2023.
PMID: 36511654
Free PMC article.